To hear about similar clinical trials, please enter your email below
Trial Title:
Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences
NCT ID:
NCT05891730
Condition:
Colorectal Cancer
Conditions: Official terms:
Colorectal Neoplasms
Conditions: Keywords:
colorectal cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical study participation percentages haven't always been fully representative of a
given demographic.
Participation in this observational clinical research is extremely valuable since it
allows people with colorectal cancer to contribute their own experiences and unique
viewpoints.
These vital contributions have the potential to affect the development of novel therapies
and support services dramatically.
Trial's findings will be critical in furthering the understanding of colorectal cancer,
ultimately leading to better patient outcomes.
Criteria for eligibility:
Study pop:
Colorectal cancer patients who are actively considering involvement in an observational
clinical study, but have not yet completed enrollment and registration.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Participant has a diagnosis of colorectal cancer
- Patient has self-identified as planning to enroll in a clinical trial for colorectal
cancer
- Patient is at least 18 years of age
Exclusion Criteria:
- Inability to perform regular electronic reporting
- Any mental or medical condition that prevents the patient from giving informed
consent or participating in the trial
- Pregnant or lactating woman
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
June 2024
Completion date:
June 2024
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05891730